Metabolic syndrome (MS) and nondipping hypertension both increase cardiovascular mortality. Although both clinical modalities share common pathophysiologic factors in their etiologies, previous studies did not find any association between them. We aimed to investigate the association between MS and non-dipping blood pressure by comparing different definitions of MS. One hundred-thirty-two consecutive patients (58 men) who underwent 24-hour ambulatory blood pressure monitoring were analyzed. MS was evaluated according to the currently used Adult Treatment Panel (ATP) III definition criteria, named MS-ATP III. In order to reveal the weights of risk contributing to MS, a new diagnostic scoring method (MS-Score) was used in comparison with MS-ATP III. Nocturnal non-dipping refers to a reduction in average systolic and/or diastolic blood pressure at night ( 10%) compared with daytime average values. Non-dipping pattern was found in 61.4% of patients. The frequency of MS according to MS-Score, but not MS ATP III, was significantly higher in patients with nondipping pattern than those without it ( p = 0.009). Although more prominent in the nighttime, MS-Score showed positive correlation with all systolic blood pressure results (r = 0.27, p = 0.002). Adjusted for baseline characteristics, high ( 27.5) MS-Score remained as an independent predictor of non-dipping pattern (OR 2.64, p = 0.038). Finally, high MS-Score, but not MS-ATP III, is a predictor of non-dipping pattern. Nighttime systolic blood pressure is higher in patients with high MS-Score. Therefore, patients with high MS-Score may be more prone to cardiovascular events than those with low MSScore.
tory factor for its main diagnostic criteria.
As it is agreed by National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP) III, obesity is considered as epidemic and its association with cardiovascular risk is the characteristic of the syndrome (NCEP 2000) . In contrast, World Heath Organization (WHO) accepts that the documentation of IR plays a pivotal role in diagnosing MS (Alberti and Zimmet 1998) . ATP III criteria, which were based on categorical presence of at least 3 of the following 5 criteria: abdominal obesity, hypertension, impaired fasting glucose, hypertriglyceridemia and low high-density lipoprotein-cholesterol (HDL-C), are used more commonly due to its simplicity. As a conclusion, both diagnostic criteria are far behind in reflecting the metabolic risk when all features are combined with each other.
Recently Macchia et al. (2006) from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI) -Prevenzione study generated a new diagnostic score for MS by giving appropriate weights of risk to each contributing component of MS rather than using their categorical presence as ATP III criteria.
Large scales of clinical trials revealed that hypertension is a classical risk factor for cardiovascular diseases. Nonetheless, antihypertensive therapies are yielding inconsistent results to reduce the risk of coronary artery disease (CAD) to the same extent as they do in stroke, heart failure and renal insufficiency (Weber 1987 (Weber , 1989 . Therefore, it may be concluded that hypertension is a broader condition than just being a high level of blood pressure.
The close relationship of hypertension with IR and glucose intolerance may explain its broader effect and also makes it one of the components of MS (Modan et al. 1985) . Furthermore, subgroup of hypertensive subjects with the lack of nocturnal decline in blood pressure referred as "non-dipping pattern" has been associated with a greater extent of cardiac and extra-cardiac target organ damages (Bianchi et al. 1994; Cuspidi et al. 2004a) .
Despite the high frequency of non-dipping pattern in diabetes mellitus (DM) (Perk et al. 2002 ) and its close relationship with IR (Della Mea et al. 2005) , the association of non-dipping pattern with MS surprisingly failed to be proven (Cuspidi et al. 2004c ). This might be due to the inadequacy of the diagnostic method of MS to reflect the excess risk contributed to this syndrome. Therefore, using new MS-Score method, the present study aimed to examine if another definition criteria for MS have a difference for revealing the association of MS with nocturnal non-dipping blood pressure.
MATERIALS AND METHODS

Study population
The study population included 132 consecutive patients with essential hypertension receiving antihypertensive treatment. They were referred to our clinic for evaluation of antihypertensive treatment response with ambulatory blood pressure monitoring (ABPM). Hypertension was determined with documented history of hypertension with the necessity of medical treatment.
Patients who had any of the following conditions such as secondary hypertension, congestive heart failure, previous myocardial infarction, cardiac valve disease, chronic renal failure and any conditions preventing technically adequate ABPM (e.g., atrial fibrillation and any other arrhythmias) are excluded from the study. All of the subjects were evaluated by a detailed questionnaire and a physical examination. The questionnaire provided information about risk factors such as smoking, past medical history, diabetes mellitus, hypertension duration and the medical treatment. The study protocol was approved by the ethics committee and informed consent was obtained from all of the patients.
Definition of metabolic syndrome
MS, according to NCEP-ATP III report (2002) is defined as a medical condition satisfying at least 3 of the following 5 criteria: (i) Hypertension (history of hypertension, systolic blood pressure 130 mmHg, diastolic blood pressure 85 mmHg or anti hypertensive treatment), (ii) Triglycerides 150 mg/dl, (iii) HDL-C < 40 mg/dl for men and < 50 mg/dl for women, (iv) Fasting blood glucose (FG) level 110 mg/dl, and (v) Abdominal obesity (waist circumference > 102 cm in men and > 88 cm in women). Waist circumference was measured at the midpoint between the bottom of the rib cage and above the top of the iliac crest from patients at breath hold after full expiration. MS evaluation accord-period of application and the device type were identical for all patients. During the ABPM, patients are instructed to continue their usual daily activities but to keep their arms still at the times of measurements; in addition, all were asked to go to sleep no later than 22 : 00 at night and not to get up before 06 : 00 in the morning. After completion of 24-hour measurements, with a minimum of 80% valid readings, test was accepted. Recordings were analyzed to obtain 24-hour daytime and nighttime averages of systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MABP), the degree of day-night decrease in SBP and DBP and the difference of day-night average MABP.
Determination of dipping and non-dipping patterns
Nocturnal non-dipping refers to a 10% or lesser magnitude reduction in average SBP and/or DBP at nighttime compared to daytime SBP average values (Takakuwa et al. 2001 ). The remainder defined as dipper.
Statistical analysis
Statistical analysis was carried out by using the SPSS for Windows (release 11.5 Software Package, Chicago, IL, USA). Quantitative variables are expressed as mean values (S.D.), and qualitative variables are expressed as percentages (%). Comparison of parametric values between two groups was performed by means of two-tailed Student's t-test. Categorical variables were compared by the chi-squared test. Spearman rho's and Pearson tests were used for correlation analysis. To define high MS-Score, receiver-operating characteristic curves were constructed and the suitable cut-off point, where the sensitivity for the prediction of non-dipping status nearly equal to specificity, was determined. Multivariate logistic regression analysis was used to identify independent predictors for the development of the non-dipping status. A value of p < 0.05 was considered as statistically significant.
RESULTS
Patient characteristics
The study population consists of 58 men and 74 women (mean age of 52 ± 12.6 years). Mean 24-h SBP and DBP were 122 ± 13.8 and 70.9 ± 10.3 mmHg. The overall prevalence of MS according to ATP III criteria was 59.8% and average MS-Score was 33.4 ± 11.1 points. Diabetes found to be present in 11.3% of 132 patients.
ing to NCEP-ATP III was named as MS-ATP III. MSScore was calculated for each subject by summing all the points that were assigned for different intervals of 7 risk factors (Macchia et al. 2006 ). These 7 risk factors included: (i) Male gender, (ii) Age > 50 years, (iii) Presence of hypertension, (iv) Body mass index (BMI), (v) HDL-C, (vi) Triglycerides, and (vii) Fasting glucose. Risk points (Table 1) have been mentioned in the original article by Macchia et al. (2006) .
Ambulatory blood pressure monitoring (ABPM)
Twenty-four-hour ABPM was carried out on the non dominant arm using Reynolds Medical Tracker NIBP2 device (Reynolds Medical Ltd., Hertford, UK) after validation of its readings. The device was set to obtain blood pressure readings at 15-min intervals during the day (between 06 : 00 and 22 : 00 h) and at 20-min intervals during the night (between 22 : 00 and 06 : 00 h). The The means of each individual component of MS other than high blood pressure were as follows: glucose, 5.8 ± 0.9 mmol/l; high density lipoprotein, 1.3 ± 0.3 mmol/l; triglyceride, 1.6 ± 0.6 mmol/l; and waist circumference, 92.7 ± 12.2 cm.
The most common administered antihypertensive drug was angiotensin-converting enzyme inhibitor (65%), which was followed by a betablocker (39.3%), calcium channel blocker (33%) and angiotensin II receptor blocker (23.4%).
Non-dipping status and MS-score
Patients were divided into two groups according to those with dipping pattern (n = 51, 38.6%) and those with non-dipping pattern (n = 81, 61.4%). There were no significant differences in age, sex, coronary risk factors, type of antihypertensive drug groups and duration of hypertension between the subgroups (Table 2 ). The existence of MS according to ATP III criteria was insignificant between two subgroups but mean MS-Score was significantly higher in the nondipping group (35.6 ± 11.4, 30.35 ± 9.9, p = 0.009, respectively) than that of dipping group.
High MS-Score was defined as a MS-Score 27.5, which was the optimal cut-off point to differentiate the patients having non-dipping feature, based on the receiver-operating characteristic curve analysis (sensitivity 77%, specifity 53%). The mean MS-Score level of 89 patients (67.4%) in high MS-Score group was 39.3 ± 8.2. There were no significant differences in age, gender, smoking, low-density lipoprotein-cholesterol (LDL-C), HDL-C and antihypertensive treatment regimens among the patients with and without high MS-Score (Table 3) .
Because age ( p < 0.001), BMI ( p < 0.001), triglycerides ( p = 0.007) and FG ( p < 0.001) are contributing parameters of the MS-Score, these were significantly high in the group of patients having high MS-Score. Presence of MS, according to MS-ATP III definition occurred significantly higher in patients with high MS-Score (73%) than in patients with low MS-Score (33%) ( p < 0.001). Similarly, non-dipping status was also significantly higher on patients with high MSScore than that of patients with low MS-Score (70%, 44%, p < 0.005, respectively).
As it was expected, nighttime values of MABP, SBP and DBP were significantly higher in non-dipper group than those of dipper group ( p < 0.001). Similarly nighttime SBP was significantly higher in high MS-Score group than it was in low MS-Score group (117 ± 16.1, 109.6 ± 12.6, p = 0.005, respectively) (Tables 4-5). Even though it is more prominent with nighttime SBP, MS-Score was found to have low-medium positive correlation with all of the SBP results but there was no correlation with DBP results (Tables 6-7, Fig. 1 ).
Determinants of non-dipping status
Multivariate logistic regression analysis was used to determine the independent factors related to the development of the non-dipping status. Along with the MS-Score level, following variables have been used: Age, male gender, FG, BMI, waist circumference, hypertension duration, triglycerides, HDL-C and presence of MS according to ATP III. (Table 8) .
DISCUSSION
This is the first cross-sectional study comparing the effects and relations of MS with different approaches such as MS-ATP III and MS-Score on non-dipping blood pressure. This study was able to show that a high MS-Score, but not MS-ATP III, predicts non-dipping blood pressure. A significant relationship is present between increasing MS-Score and all systolic blood pressures, particularly with nighttime SBP. These results provide new information about the relationship between MS-Score and non-dipping blood pressure.
Various other studies investigating the effects of dipping and non-dipping patterns demonstrated that patients with non-dipping pattern have been associated with an increased risk of end-organ damage (Cuspidi et al. 2004a ) such as cerebrovascular and cardiovascular complications than other patients with dipping pattern (Staessen et al. 1999; Kario et al. 2001; Higashi et al. 2002) . Although underlying mechanisms are still unknown, sympathetic over activity, functional and structural vascular alterations, early autonomic neuropathy have all been seen in patients with non-dipping BP (Hommel et al. 1989; Sherwood et al. 2002) . Insulin resistance is the underlying mechanisms of both MS and hypertension (Modan et al. 1985; Swislocki et al. 1989) . In IR states high plasma levels of insulin results in hypertension by inducing proliferation on vascular smooth muscles which cause alterations in structure and function of the arteries (Banskota et al. 1989) . These alterations are thought to play an important role in non-dipping BP.
Several other studies investigated the relationship between diurnal blood pressure and MS but they failed to find such relation (Foss et al. 2000; Cuspidi et al. 2004a) . In contrast, the findings of this study were consistent to show a close relation with MS-Score but not with MS-ATP III which was used in the determination of all previous MS studies.
In order to show more accurate relation with these two clinical conditions, MS-Score was used instead of MS-ATP III diagnostic criteria. Macchia et al. (2006) developed an easy clinical scoring system (Table 1) which can measure the weights of risk increasing progressively as the intensity level of MS components increase. Macchia et al. (2006) found a MS-Score cut-off point of 28 as the best compromise between sensitivity and specificity for MS diagnosis. In the same study, patients with low MS-Score (< 28) were at lower risk of getting DM (20.7%, RR 3.22, 95% CI 2.81 -3.68, p < 0.0001). Macchia et al. (2006), also indicated that high MS-Score ( 27.5) was diagnostic for MS. In addition, no DM was observed in low MS-Score group. Positive correlation of MS-Score with nighttime SBP might be noteworthy in interpretation of most types of cardiovascular diseases follows a circadian pattern.
It is also important to emphasize that despite all of the MS-ATP III diagnostic components, only MS-Score was able to predict non-dipping pattern. Not surprisingly, MS-Score's superior ability to predict non-dipping pattern is a natural result of assigning different weights to each risk factor. In other words, MS-ATP III undermines its capability of predicting non-dipping pattern accurately by using the equal weights for each risk factor. This approach would not represent the true metabolic risk. All in all, due to the fact that some risk factors play a more important role than others do in determining the risk attributed to this syndrome. MS-ATP III clearly overlooks the importance of treating these 5 risk factors differently. In fact, MS-Scoring method, which treats each risk factor separately, would be able to produce more meaningful results, giving different points of calculations and yielding better results in estimating metabolic risk. Since it is considered that the arterial modifications due to IR occur even before the appearance of the clinical hypertension, early determination of MS may provide important early evaluation of non-dipping BP and other related cardiovascular risks.
Study limitations
There were few limitations to this study. First, the sample size used was limited. Second as suggested by Cuspidi et al. (2004a) , ABPM would have been applied to the patients twice due to the 25% chance of reproducibility of dipping/non-dipping patterns. However, in this study due to limited resources, ABPM could only be performed once. So it is hard to conclude in certainty that reproducibility rates of non-dipping blood pressure of our laboratory experiment reflect the most dependable and flawless results. Finally, Macchia et al. (2006) used MS-Score both in predicting DM development and MS diagnosing; glucose shared the highest assigned points in calculation of the MS-Score. Therefore, even under 100 mg/dl fasting glucose levels were assigned a point in score calculation in order to predict DM. Nevertheless, it is worth noting that fasting glucose levels that are considered to be in normal limits were also associated with 2-3 fold increase in getting DM and creating some DM complications i.e., hypertension.
CONCLUSION
Reduced nocturnal blood pressure fall is considered one of the clinical traits associated with a greater cardiovascular risk and end organ damage (Bianchi et al. 1994; Cuspidi et al. 2004b) . Hypertension is one of the major components of MS and non-dipping blood pressure that was shown to be related with MS. The effects of each MS feature are greater than their categorical added fashion. This may indicate the importance of evaluation of the MS from a different perspective that may reveal various expected relationships attributed to this syndrome.
As a result, this simple scoring method which can be easily obtained and applied to all patients may provide important information about non-dipping pattern and especially increased nighttime SBP in those who have high MS-Score.
